General Information of the Compound
Compound ID
CP0286473
Compound Name
LLL-12
    Show/Hide
Synonyms
LLL-12
PMID26394986-Compound-43
    Show/Hide
Structure
Formula
C14H9NO5S
Molecular Weight
303.295
Canonical SMILES
NS(=O)(=O)c1cccc2C(=O)c3c(O)cccc3C(=O)c12
    Show/Hide
InChI
InChI=1S/C14H9NO5S/c15-21(19,20)10-6-2-4-8-12(10)14(18)7-3-1-5-9(16)11(7)13(8)17/h1-6,16H,(H2,15,19,20)
    Show/Hide
InChIKey
CQBHSRLUQDYPBU-UHFFFAOYSA-N
Physicochemical Property
logP
0.815
Rotatable Bonds
1
Heavy Atom Count
21
Polar Areas
114.53
Hydrogen Bond Donor Count
2
Hydrogen Bond Acceptor Count
5
Complexity
21

"RO5" indicates the cutoff set by lipinski's rule of five:

(1) Molecular weight less than 500 Dalton;

(2) xlogp less than 5;

(3) No more than 5 hbonddonor (Hydrogen Bond Donor Count);

(4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count);

(5) No more than 10 rotbonds (Rotatable Bond Count).

    Show/Hide
Click to Show/Hide the External Link(s) of This Compound
PubChem ID
CID: 46911017
SID: 99371998
ChEMBL ID
CHEMBL2380760
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound

Compound
Cell Line
Protein

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT01503, Signal transducer and activator of transcription 3
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000063 Hep-G2 Homo sapiens (Human)  1
1
IC50 = 98 nM
   TI
   LI
   LO
   TS
Clinical Information about the Compound
Drug 1 ( PMID26394986-Compound-43 )
Drug Name PMID26394986-Compound-43
Company The Ohio University
Target(s)
Signal transducer and activator of transcription 3 (STAT3)
Inhibitor
Drug 2 ( LLL-12 )
Drug Name LLL-12
Company Ohio State University
Indication
Solid tumour/cancer
Investigative